The global market for chromoendoscopy agents is anticipated to witness a positive growth curve over the coming years. According to a recent report by Transparency Market Research (TMR), rising inclination of the masses toward minimally invasive procedures is predicted to influence the market growth. The report, titled, “Chromoendoscopy Agents Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” discusses the various factors that are accountable for the growth of the overall industry and also chronicles upcoming market trends.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37196
In earlier times, physicians used to perform endoscopy for the diagnosis of disorders by detecting the abnormal gut part and collecting the sample using cytology brush or biopsy forceps. Chromoendoscopy, however, provides real time differentiation between abnormal and normal cells, which improves the accuracy and diagnosis in the detection of various diseases. The rising prevalence of esophageal and colorectal cancers is predicted to augment the demand for chromoendoscopy agents over the years to come, providing a boost to the global market.
The ease of availability of chromoendoscopy agents is projected to fuel the expansion of the market. This procedure is performed under a halogen or xenon or LED light source which generally produces white or yellow light to visualize the gut wall. Diagnostic endoscopy is performed to detect diseases and disorders such as ulcerative colitis, Barrett’s esophagus, H. pylori infection, cancer, intestinal metaplasia, and polyps.
Based on geography, Europe is anticipated to emerge as leading share holder in the global market, on account of the high number of patients diagnosed with esophageal ailments. Leading players in the global chromoendoscopy market are Histalim, Thermo Fisher Scientific, Cosmo Pharmaceuticals, Enzo Life Sciences, Merck KGaA, and Sisco Research Laboratories Pvt. Ltd.